BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xu DW, Wan P, Xia Q. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review. World J Gastroenterol 2016; 22(12): 3325-3334 [PMID: 27022214 DOI: 10.3748/wjg.v22.i12.3325]
URL: https://www.wjgnet.com/1948-5182/full/v22/i12/3325.htm
Number Citing Articles
1
Julia Herreras, Tommaso Di Maira, Carmen Vinaixa, Fernando San Juan, Ángel Rubín, Marina Berenguer. Milan-out Criteria and Worse Intention-to-Treat Outcome Postliver TransplantationTransplantation Direct 2019; 5(10): e487 doi: 10.1097/TXD.0000000000000934
2
Baoxian Liu, Guangliang Huang, Xiaohua Xie, Qiang Zhao, Liya Su, Ming Liu, Xiaoju Li, Jianting Long, Ming Kuang, Xiaoyan Xie. Feasibility and outcomes of percutaneous radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantation: a single-center experienceInternational Journal of Hyperthermia 2020; 37(1): 1202 doi: 10.1080/02656736.2020.1834154
3
Peter R. Galle, Francesco Tovoli, Friedrich Foerster, Marcus A. Wörns, Alessandro Cucchetti, Luigi Bolondi. The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapyJournal of Hepatology 2017; 67(1): 173 doi: 10.1016/j.jhep.2017.03.007
4
F.J. León Díaz, J.A. Pérez Daga, B. Sánchez Pérez, J.L. Fernández Aguilar, C. Montiel Casado, J.M. Aranda Narváez, M.A. Suárez Muñoz, L. Romacho López, J. Santoyo Villalba, J. Santoyo Santoyo. Up-to-7 Criteria for Hepatocellular Carcinoma Liver Transplantation: A Retrospective Analysis of ExperiencesTransplantation Proceedings 2016; 48(9): 2969 doi: 10.1016/j.transproceed.2016.08.035
5
Wei Yang, Hao Wu, Zhong-yi Zhang, Jung-chieh Lee, Song Wang, Yan-jie Wang, Wei Wu, Min-hua Chen, Kun Yan. Long-term outcome of percutaneous radiofrequency ablation in recurrent hepatocellular carcinoma after liver transplantationInternational Journal of Hyperthermia 2018; 34(1): 68 doi: 10.1080/02656736.2017.1324179
6
Byeong Geun Song, Dong Hyun Sinn, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Jong Man Kim, Jae-Won Joh, Gyu-Seong Choi. Changes in Tumor Markers and Their Implications in Selecting Liver Transplantation for Patients With Hepatocellular CarcinomaTransplantation Proceedings 2020; 52(3): 881 doi: 10.1016/j.transproceed.2020.01.037
7
Madalyn G. Neuwirth, Christine Bierema, Andrew J. Sinnamon, Douglas L. Fraker, Rachel R. Kelz, Robert E. Roses, Giorgos C. Karakousis. Trends in major upper abdominal surgery for cancer in octogenarians: Has there been a change in patient selection?Cancer 2018; 124(1): 125 doi: 10.1002/cncr.30977
8
Pedro Eman, Eduardo Chacon, Meera Gupta, Jonathan C. Berger, Malay B. Shah, Hanine E. El Haddad, Amr El-Husseini, Anna C. Dela Cruz, Alla Grigorian, Xiaonan Mei, Roberto Gedaly. Long term outcomes of patients transplanted for hepatocellular carcinoma with human immunodeficiency virus infectionHPB 2019; 21(8): 1009 doi: 10.1016/j.hpb.2019.01.001
9
Bing Han, Han Ding, Shuai Zhao, Yichi Zhang, Jian Wang, Yue Zhang, Jinyang Gu. Potential Role of Adjuvant Lenvatinib in Improving Disease-Free Survival for Patients With High-Risk Hepatitis B Virus-Related Hepatocellular Carcinoma Following Liver Transplantation: A Retrospective, Case Control StudyFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.562103
10
David C. Mulligan. The ongoing quest to find the appropriate patients to transplant with hepatocellular carcinoma: Milan to san Francisco to Toronto and beyondHepatology 2016; 64(6): 1853 doi: 10.1002/hep.28841
11
Y. Shi, J. Chi, T. Wang, D. Cui, X. Tang, M. Ding, P. Li, B. Zhai. Mid-term outcome of percutaneous thermal ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantationClinical Radiology 2019; 74(9): 735.e1 doi: 10.1016/j.crad.2019.05.029
12
Maria Cristina Bonferoni, Elisabetta Gavini, Giovanna Rassu, Marcello Maestri, Paolo Giunchedi. Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-TargetingNanomaterials 2020; 10(5): 870 doi: 10.3390/nano10050870
13
Hae Won Lee, Kyung-Suk Suh. Advancements of liver transplantation for hepatocellular carcinoma in KoreaJapanese Journal of Clinical Oncology 2017; 47(2): 93 doi: 10.1093/jjco/hyw168
14
Patrizia Burra, Alberto Zanetto, Giacomo Germani. Liver Transplantation for Alcoholic Liver Disease and Hepatocellular CarcinomaCancers 2018; 10(2): 46 doi: 10.3390/cancers10020046
15
Sami Akbulut, Cemalettin Koc. Do We Need to Be Limited by Matching Milan Criteria for Survival in Living Donor Liver Transplantation?Journal of Gastrointestinal Cancer 2020; 51(4): 1107 doi: 10.1007/s12029-020-00482-0
16
Arno Kornberg, Helmut Friess. 18F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approachesTherapeutic Advances in Gastroenterology 2019; 12: 175628481983620 doi: 10.1177/1756284819836205
17
Young-In Yoon, Sung-Gyu Lee. Living Donor Liver Transplantation for Hepatocellular Carcinoma: An Asian PerspectiveDigestive Diseases and Sciences 2019; 64(4): 993 doi: 10.1007/s10620-019-05551-4
18
Sam E. Grigg, Gino L. Sarri, Paul J. Gow, Neville D. Yeomans. Systematic review with meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinomaAlimentary Pharmacology & Therapeutics 2019; 49(10): 1260 doi: 10.1111/apt.15253
19
Douglas N. VanDerwerken, Nicholas L. Wood, Dorry L. Segev, Sommer E. Gentry. The Precise Relationship Between Model for End‐Stage Liver Disease and Survival Without a Liver TransplantHepatology 2021; 74(2): 950 doi: 10.1002/hep.31781
20
Can KARACA, Cahit Hüseyin YILMAZ. Hepatoselüler kanser için karaciğer nakli: Altı yıllık deneyimin öğrettikleriEge Tıp Dergisi 2020; : 265 doi: 10.19161/etd.834132
21
Yukimasa Makita, Shumpei Murata, Yoshiki Katou, Kuniko Kikuchi, Hiroshi Uejima, Mika Teratani, Yasutaka Hoashi, Eriya Kenjo, Satoru Matsumoto, Masahiro Nogami, Kentaro Otake, Yuji Kawamata. Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinomaBiochemical and Biophysical Research Communications 2017; 493(1): 800 doi: 10.1016/j.bbrc.2017.08.088
22
C. Yilmaz, C.A. Karaca, Z. Iakobadze, R. Farajov, K. Kilic, L. Doganay, M. Kilic. Factors Affecting Recurrence and Survival After Liver Transplantation for Hepatocellular CarcinomaTransplantation Proceedings 2018; 50(10): 3571 doi: 10.1016/j.transproceed.2018.05.027
23
Sam Grigg, Paul Gow, Neville Yeomans. Sirolimus in Liver Transplant Recipients With Hepatocellular CarcinomaJournal of Investigative Surgery 2020; 33(4): 389 doi: 10.1080/08941939.2018.1513103
24
Jie Han, Yu-chen Fan, Kai Wang. Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinomaMedicine 2020; 99(43): e22703 doi: 10.1097/MD.0000000000022703